Feedback

Prof. Dharmarajan Sriram

Senior Professor
Department of Pharmacy

Tuberculosis drug discovery, Other antimicrobial drug discovery
Room No: B224,
Department of Pharmacy,
Birla Institute of Technology & Science, Pilani,
Hyderabad Campus Jawahar Nagar, Kapra Mandal,
Dist.-Medchal-500 078,
Telangana, India

 

Tuberculosis drug discovery
Main TB targets: Enzymes involved in DNA synthesis, cell wall synthesis, signaling pathway, dormancy, shikimate pathway, amino acid biosynthesis.

Host directed TB therapy

Other antimicrobial drug discovery

Antibacterial drugs: ESKAPE organisms majorly Staphylococcus aureus and Pseudomonas aeruginosa

 

Antibacterial drugs: ESKAPE organisms majorly Staphylococcus aureus and Pseudomonas aeruginosa
 
Collaborative Research Scientist at:
 

1. Karolinska Institute, Sweden.

2. N.I.I. New Delhi, India.

3. Institute of Science and Technology for Tuberculosis, Technopuc, Brazil 
 
4. The Global Alliance for TB Drug Development Inc. NY.
 
5. Institute of Medical Biology, Lodz, Poland.